10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The safety, tolerability and effectiveness of generic antiretroviral drug regimens for HIV-infected patients in south India.

      AIDS (London, England)
      Adult, Anti-HIV Agents, adverse effects, Antiretroviral Therapy, Highly Active, CD4 Lymphocyte Count, methods, Cohort Studies, Female, HIV Infections, drug therapy, epidemiology, Humans, India, Male, Nevirapine, Withholding Treatment

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          We investigated the safety, tolerability and effectiveness of locally produced generic highly active antiretroviral therapy (HAART) regimens with a chart review conducted at YRG CARE, a tertiary HIV referral centre in India. A total of 333 patients had been on Indian-manufactured generic HAART for at least 3 months. In this cohort, generic HAART was safe, well tolerated and effective at increasing CD4 T-lymphocyte counts in patients with advanced HIV, comparable to the experience with proprietary HAART.

          Related collections

          Author and article information

          Comments

          Comment on this article